192 related articles for article (PubMed ID: 32634277)
1. Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels.
Crane J; Manfredo J; Boscolo E; Coyan M; Takemoto C; Itkin M; Adams DM; Le Cras TD
Pediatr Blood Cancer; 2020 Sep; 67(9):e28529. PubMed ID: 32634277
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder.
Fernandes VM; Fargo JH; Saini S; Guerrera MF; Marcus L; Luchtman-Jones L; Adams D; Meier ER
Pediatr Blood Cancer; 2015 May; 62(5):901-4. PubMed ID: 25307772
[TBL] [Abstract][Full Text] [Related]
3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
4. How we use angiopoietin-2 in the diagnosis and management of vascular anomalies.
Engel ER; Le Cras TD; Ricci KW
Pediatr Blood Cancer; 2024 May; 71(5):e30921. PubMed ID: 38439088
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
6. Combined Transarterial Sclerotherapy and Embolization with Systemic Chemotherapy Followed by Everolimus in Kaposiform Hemangioendothelioma with Kasabach-Merritt Syndrome.
Hermawan R; Syarif AH; Mahdi HIS; Mukarramah DA
J Vasc Interv Radiol; 2021 May; 32(5):768-771. PubMed ID: 33707126
[No Abstract] [Full Text] [Related]
7. Cellular variant of kaposiform lymphangiomatosis: a report of three cases, expanding the morphologic and molecular genetic spectrum of this rare entity.
Allen-Rhoades W; Al-Ibraheemi A; Kohorst M; Tollefson M; Hull N; Polites S; Folpe AL
Hum Pathol; 2022 Apr; 122():72-81. PubMed ID: 35202617
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
[TBL] [Abstract][Full Text] [Related]
9. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
10. Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly.
Croteau SE; Kozakewich HP; Perez-Atayde AR; Fishman SJ; Alomari AI; Chaudry G; Mulliken JB; Trenor CC
J Pediatr; 2014 Feb; 164(2):383-8. PubMed ID: 24252784
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
[TBL] [Abstract][Full Text] [Related]
12. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
[TBL] [Abstract][Full Text] [Related]
13. Splenic kaposiform hemangioendothelioma presenting as insidious consumptive coagulopathy.
Goldenberg M; Shiel M; Subramanian S; Kalpatthi R; Reyes-Múgica M; Nolfi-Donegan D
Am J Hematol; 2021 Dec; 96(12):1708-1714. PubMed ID: 34622468
[No Abstract] [Full Text] [Related]
14. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
Croteau SE; Gupta D
Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
[TBL] [Abstract][Full Text] [Related]
15. Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
Ji Y; Chen S; Peng S; Xia C; Li L
Orphanet J Rare Dis; 2019 Jul; 14(1):165. PubMed ID: 31277673
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis.
Boscolo E; Pastura P; Glaser K; Goines J; Hammill AM; Adams DM; Dickie P; Hsi Dickie B; Le Cras TD
Pediatr Blood Cancer; 2019 Aug; 66(8):e27790. PubMed ID: 31045327
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T;
Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291
[TBL] [Abstract][Full Text] [Related]
18. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
19. Vascular tumors.
Mansfield SA; Williams RF; Iacobas I
Semin Pediatr Surg; 2020 Oct; 29(5):150975. PubMed ID: 33069294
[TBL] [Abstract][Full Text] [Related]
20. Microscopic Kaposiform hemangioendothelioma with extensive lymphangiomatosis: an extraordinary example of an unusual entity.
Low IC; Yang RY; Symmans PJ
Int J Surg Pathol; 2013 Jun; 21(3):297-302. PubMed ID: 23129838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
